ArticleScientific reports2026
Essential role for the urothelial plaque in Gram-negative urinary tract infections.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Over 90% of urinary tract infections (UTI) are caused by Gram-negative bacteria, especially uropathogenic Escherichia coli (UPEC). Bladder superficial cells produce Uroplakin (Upk) containing urothelial plaques that bind to UPEC type I fimbriae. The role of the plaque in UPEC urothelial invasion and triggering the host inflammatory response remains unclear. In this study, we used Upk1b KO mice to test the hypothesis that a functional urothelial plaque is required for UPEC UTI. Following UPEC inoculation, Upk1b KO mice exhibited reduced bacterial burden, impaired urothelial invasion, and absent intracellular bacterial communities, compared to wild-type hosts. Transcriptome analysis identified attenuation of innate immune pathways in Upk1b KO bladders and flow cytometry confirmed limited phagocyte recruitment. Our results demonstrate that the plaque is essential for UPEC urothelial invasion, establishment of UTI, and initiation of the innate immune response. Notable study limitations include the potential that observations made in mouse models are associative rather than causal and that our conclusions may not fully apply to human UTI. While our findings strengthen the rationale for targeted therapies that disrupt UPEC-plaque interactions, such strategies may prove challenging given the fundamental role of the plaque in preserving urothelial integrity and barrier function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.